APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nitric Oxide Therapy System

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Selected research

Market Analysis & Forecast

Global Nitric Oxide Therapy System Market Analysis and Forecast 2026-2032

Report ID 17389498021 January 2026196 pages

Choose your research edition.

Industry ResearchNitric Oxide Therapy System Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitric Oxide Therapy System Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nitric Oxide Therapy System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitric Oxide Therapy System Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitric Oxide Therapy System Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.

Report Includes

Read the full market overview

This report presents an overview of global market for Nitric Oxide Therapy System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nitric Oxide Therapy System, also provides the revenue of main regions and countries. Of the upcoming market potential for Nitric Oxide Therapy System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nitric Oxide Therapy System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nitric Oxide Therapy System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nitric Oxide Therapy System revenue, projected growth trends, production technology, application and end-user industry.

Nitric Oxide Therapy System Segment by Company

Bellerophon Therapeutics

BOC Healthcare

Dan Hammer Health

EKU Elektronik GmbH

GeNO LLC

International Biomedical

SLE

Mallinckrodt Pharmaceuticals

Praxair,

Vapotherm

Linde Group

Nitric Oxide Therapy System Segment by Type

Protable System

Fixed System

Nitric Oxide Therapy System Segment by Application

Hospitals

Homecare Settings

Others

Nitric Oxide Therapy System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitric Oxide Therapy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitric Oxide Therapy System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitric Oxide Therapy System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nitric Oxide Therapy System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nitric Oxide Therapy System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nitric Oxide Therapy System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nitric Oxide Therapy System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protable System Major Player Table 3. Fixed System Major Player Table 4. Global Nitric Oxide Therapy System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Homecare Settings Major Player Table 7. Others Major Player Table 8. Nitric Oxide Therapy System Industry Trends Table 9. Nitric Oxide Therapy System Industry Drivers Table 10. Nitric Oxide Therapy System Industry Opportunities and Challenges Table 11. Nitric Oxide Therapy System Industry Restraints Table 12. Global Nitric Oxide Therapy System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Nitric Oxide Therapy System Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Nitric Oxide Therapy System Market Share by Region (2021-2026) Table 15. Global Nitric Oxide Therapy System Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Nitric Oxide Therapy System Market Share by Region (2027-2032) Table 17. Global Nitric Oxide Therapy System Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Nitric Oxide Therapy System Revenue Market Share by Players (2021-2026) Table 19. Global Nitric Oxide Therapy System Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Nitric Oxide Therapy System Key Players Headquarters & Area Served Table 21. Global Nitric Oxide Therapy System Players, Product Type & Application Table 22. Global Nitric Oxide Therapy System Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Nitric Oxide Therapy System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Nitric Oxide Therapy System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Nitric Oxide Therapy System Revenue Market Share by Type (2021-2026) Table 29. Global Nitric Oxide Therapy System Revenue Market Share by Type (2027-2032) Table 30. Global Nitric Oxide Therapy System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Nitric Oxide Therapy System Revenue Market Share by Application (2021-2026) Table 34. Global Nitric Oxide Therapy System Revenue Market Share by Application (2027-2032) Table 35. Bellerophon Therapeutics Company Information Table 36. Bellerophon Therapeutics Business Overview Table 37. Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio Table 39. Bellerophon Therapeutics Recent Development Table 40. BOC Healthcare Company Information Table 41. BOC Healthcare Business Overview Table 42. BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BOC Healthcare Nitric Oxide Therapy System Product Portfolio Table 44. BOC Healthcare Recent Development Table 45. Dan Hammer Health Company Information Table 46. Dan Hammer Health Business Overview Table 47. Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dan Hammer Health Nitric Oxide Therapy System Product Portfolio Table 49. Dan Hammer Health Recent Development Table 50. EKU Elektronik GmbH Company Information Table 51. EKU Elektronik GmbH Business Overview Table 52. EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio Table 54. EKU Elektronik GmbH Recent Development Table 55. GeNO LLC Company Information Table 56. GeNO LLC Business Overview Table 57. GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GeNO LLC Nitric Oxide Therapy System Product Portfolio Table 59. GeNO LLC Recent Development Table 60. International Biomedical Company Information Table 61. International Biomedical Business Overview Table 62. International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. International Biomedical Nitric Oxide Therapy System Product Portfolio Table 64. International Biomedical Recent Development Table 65. SLE Company Information Table 66. SLE Business Overview Table 67. SLE Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SLE Nitric Oxide Therapy System Product Portfolio Table 69. SLE Recent Development Table 70. Mallinckrodt Pharmaceuticals Company Information Table 71. Mallinckrodt Pharmaceuticals Business Overview Table 72. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio Table 74. Mallinckrodt Pharmaceuticals Recent Development Table 75. Praxair, Company Information Table 76. Praxair, Business Overview Table 77. Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Praxair, Nitric Oxide Therapy System Product Portfolio Table 79. Praxair, Recent Development Table 80. Vapotherm Company Information Table 81. Vapotherm Business Overview Table 82. Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Vapotherm Nitric Oxide Therapy System Product Portfolio Table 84. Vapotherm Recent Development Table 85. Linde Group Company Information Table 86. Linde Group Business Overview Table 87. Linde Group Nitric Oxide Therapy System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Linde Group Nitric Oxide Therapy System Product Portfolio Table 89. Linde Group Recent Development Table 90. North America Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Nitric Oxide Therapy System Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Nitric Oxide Therapy System Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Nitric Oxide Therapy System Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Nitric Oxide Therapy System Revenue by Country (US$ Million) & (2027-2032) Table 104. China Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 105. China Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 106. China Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 107. China Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Nitric Oxide Therapy System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Nitric Oxide Therapy System Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Nitric Oxide Therapy System Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Nitric Oxide Therapy System Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Nitric Oxide Therapy System Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Nitric Oxide Therapy System Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Nitric Oxide Therapy System Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Nitric Oxide Therapy System Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Nitric Oxide Therapy System Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Nitric Oxide Therapy System Image Figure 2. Global Nitric Oxide Therapy System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitric Oxide Therapy System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protable System Image Figure 5. Fixed System Image Figure 6. Global Nitric Oxide Therapy System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Nitric Oxide Therapy System Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Homecare Settings Image Figure 10. Others Image Figure 11. Global Nitric Oxide Therapy System Market Size (US$ Million) & (2021-2032) Figure 12. Global Nitric Oxide Therapy System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nitric Oxide Therapy System Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Nitric Oxide Therapy System Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Nitric Oxide Therapy System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nitric Oxide Therapy System Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Nitric Oxide Therapy System Revenue Market Share by Type (2021-2032) Figure 19. Global Nitric Oxide Therapy System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Nitric Oxide Therapy System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Nitric Oxide Therapy System Revenue Market Share by Application (2021-2032) Figure 22. North America Nitric Oxide Therapy System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Nitric Oxide Therapy System Revenue Share by Type (2021-2032) Figure 24. North America Nitric Oxide Therapy System Revenue Share by Application (2021-2032) Figure 25. North America Nitric Oxide Therapy System Revenue Share by Country (2021-2032) Figure 26. United States Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Nitric Oxide Therapy System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Nitric Oxide Therapy System Revenue Share by Type (2021-2032) Figure 31. Europe Nitric Oxide Therapy System Revenue Share by Application (2021-2032) Figure 32. Europe Nitric Oxide Therapy System Revenue Share by Country (2021-2032) Figure 33. Germany Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Nitric Oxide Therapy System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Nitric Oxide Therapy System Revenue Share by Type (2021-2032) Figure 43. China Nitric Oxide Therapy System Revenue Share by Application (2021-2032) Figure 44. Asia Nitric Oxide Therapy System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Nitric Oxide Therapy System Revenue Share by Type (2021-2032) Figure 46. Asia Nitric Oxide Therapy System Revenue Share by Application (2021-2032) Figure 47. Asia Nitric Oxide Therapy System Revenue Share by Region (2021-2032) Figure 48. Japan Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Nitric Oxide Therapy System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Nitric Oxide Therapy System Revenue Share by Type (2021-2032) Figure 56. SAMEA Nitric Oxide Therapy System Revenue Share by Application (2021-2032) Figure 57. SAMEA Nitric Oxide Therapy System Revenue Share by Country (2021-2032) Figure 58. Brazil Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Nitric Oxide Therapy System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Protable System
  • Fixed System
Applications
  • Hospitals
  • Homecare Settings
  • Others
Companies covered
  • Bellerophon Therapeutics
  • BOC Healthcare
  • Dan Hammer Health
  • EKU Elektronik GmbH
  • GeNO LLC
  • International Biomedical
  • SLE
  • Mallinckrodt Pharmaceuticals
  • Praxair,
  • Vapotherm
  • Linde Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nitric Oxide Therapy System Market by Type
  3. 1.2.1 Global Nitric Oxide Therapy System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protable System
  5. 1.2.3 Fixed System
  6. 1.3 Nitric Oxide Therapy System Market by Application
  7. 1.3.1 Global Nitric Oxide Therapy System Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Homecare Settings
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Nitric Oxide Therapy System Market Dynamics
  1. 2.1 Nitric Oxide Therapy System Industry Trends
  2. 2.2 Nitric Oxide Therapy System Industry Drivers
  3. 2.3 Nitric Oxide Therapy System Industry Opportunities and Challenges
  4. 2.4 Nitric Oxide Therapy System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nitric Oxide Therapy System Market Perspective (2021-2032)
  2. 3.2 Global Nitric Oxide Therapy System Growth Trends by Region
  3. 3.2.1 Global Nitric Oxide Therapy System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nitric Oxide Therapy System Market Size by Region (2021-2026)
  5. 3.2.3 Global Nitric Oxide Therapy System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nitric Oxide Therapy System Revenue by Players
  2. 4.1.1 Global Nitric Oxide Therapy System Revenue by Players (2021-2026)
  3. 4.1.2 Global Nitric Oxide Therapy System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nitric Oxide Therapy System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nitric Oxide Therapy System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nitric Oxide Therapy System Key Players Headquarters & Area Served
  7. 4.4 Global Nitric Oxide Therapy System Players, Product Type & Application
  8. 4.5 Global Nitric Oxide Therapy System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nitric Oxide Therapy System Market CR5 and HHI
  11. 4.6.3 2025 Nitric Oxide Therapy System Tier 1, Tier 2, and Tier 3
5 Nitric Oxide Therapy System Market Size by Type
  1. 5.1 Global Nitric Oxide Therapy System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 5.3 Global Nitric Oxide Therapy System Revenue Market Share by Type (2021-2032)
6 Nitric Oxide Therapy System Market Size by Application
  1. 6.1 Global Nitric Oxide Therapy System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nitric Oxide Therapy System Revenue by Application (2021-2032)
  3. 6.3 Global Nitric Oxide Therapy System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bellerophon Therapeutics
  2. 7.1.1 Bellerophon Therapeutics Company Information
  3. 7.1.2 Bellerophon Therapeutics Business Overview
  4. 7.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio
  6. 7.1.5 Bellerophon Therapeutics Recent Developments
  7. 7.2 BOC Healthcare
  8. 7.2.1 BOC Healthcare Company Information
  9. 7.2.2 BOC Healthcare Business Overview
  10. 7.2.3 BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BOC Healthcare Nitric Oxide Therapy System Product Portfolio
  12. 7.2.5 BOC Healthcare Recent Developments
  13. 7.3 Dan Hammer Health
  14. 7.3.1 Dan Hammer Health Company Information
  15. 7.3.2 Dan Hammer Health Business Overview
  16. 7.3.3 Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dan Hammer Health Nitric Oxide Therapy System Product Portfolio
  18. 7.3.5 Dan Hammer Health Recent Developments
  19. 7.4 EKU Elektronik GmbH
  20. 7.4.1 EKU Elektronik GmbH Company Information
  21. 7.4.2 EKU Elektronik GmbH Business Overview
  22. 7.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio
  24. 7.4.5 EKU Elektronik GmbH Recent Developments
  25. 7.5 GeNO LLC
  26. 7.5.1 GeNO LLC Company Information
  27. 7.5.2 GeNO LLC Business Overview
  28. 7.5.3 GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GeNO LLC Nitric Oxide Therapy System Product Portfolio
  30. 7.5.5 GeNO LLC Recent Developments
  31. 7.6 International Biomedical
  32. 7.6.1 International Biomedical Company Information
  33. 7.6.2 International Biomedical Business Overview
  34. 7.6.3 International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 International Biomedical Nitric Oxide Therapy System Product Portfolio
  36. 7.6.5 International Biomedical Recent Developments
  37. 7.7 SLE
  38. 7.7.1 SLE Company Information
  39. 7.7.2 SLE Business Overview
  40. 7.7.3 SLE Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SLE Nitric Oxide Therapy System Product Portfolio
  42. 7.7.5 SLE Recent Developments
  43. 7.8 Mallinckrodt Pharmaceuticals
  44. 7.8.1 Mallinckrodt Pharmaceuticals Company Information
  45. 7.8.2 Mallinckrodt Pharmaceuticals Business Overview
  46. 7.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio
  48. 7.8.5 Mallinckrodt Pharmaceuticals Recent Developments
  49. 7.9 Praxair,
  50. 7.9.1 Praxair, Company Information
  51. 7.9.2 Praxair, Business Overview
  52. 7.9.3 Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Praxair, Nitric Oxide Therapy System Product Portfolio
  54. 7.9.5 Praxair, Recent Developments
  55. 7.10 Vapotherm
  56. 7.10.1 Vapotherm Company Information
  57. 7.10.2 Vapotherm Business Overview
  58. 7.10.3 Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Vapotherm Nitric Oxide Therapy System Product Portfolio
  60. 7.10.5 Vapotherm Recent Developments
  61. 7.11 Linde Group
  62. 7.11.1 Linde Group Company Information
  63. 7.11.2 Linde Group Business Overview
  64. 7.11.3 Linde Group Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Linde Group Nitric Oxide Therapy System Product Portfolio
  66. 7.11.5 Linde Group Recent Developments
8 North America
  1. 8.1 North America Nitric Oxide Therapy System Revenue (2021-2032)
  2. 8.2 North America Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 8.2.1 North America Nitric Oxide Therapy System Revenue by Type (2021-2026)
  4. 8.2.2 North America Nitric Oxide Therapy System Revenue by Type (2027-2032)
  5. 8.3 North America Nitric Oxide Therapy System Revenue Share by Type (2021-2032)
  6. 8.4 North America Nitric Oxide Therapy System Revenue by Application (2021-2032)
  7. 8.4.1 North America Nitric Oxide Therapy System Revenue by Application (2021-2026)
  8. 8.4.2 North America Nitric Oxide Therapy System Revenue by Application (2027-2032)
  9. 8.5 North America Nitric Oxide Therapy System Revenue Share by Application (2021-2032)
  10. 8.6 North America Nitric Oxide Therapy System Revenue by Country
  11. 8.6.1 North America Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nitric Oxide Therapy System Revenue by Country (2021-2026)
  13. 8.6.3 North America Nitric Oxide Therapy System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nitric Oxide Therapy System Revenue (2021-2032)
  2. 9.2 Europe Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nitric Oxide Therapy System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nitric Oxide Therapy System Revenue by Type (2027-2032)
  5. 9.3 Europe Nitric Oxide Therapy System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nitric Oxide Therapy System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nitric Oxide Therapy System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nitric Oxide Therapy System Revenue by Application (2027-2032)
  9. 9.5 Europe Nitric Oxide Therapy System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nitric Oxide Therapy System Revenue by Country
  11. 9.6.1 Europe Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nitric Oxide Therapy System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nitric Oxide Therapy System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nitric Oxide Therapy System Revenue (2021-2032)
  2. 10.2 China Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 10.2.1 China Nitric Oxide Therapy System Revenue by Type (2021-2026)
  4. 10.2.2 China Nitric Oxide Therapy System Revenue by Type (2027-2032)
  5. 10.3 China Nitric Oxide Therapy System Revenue Share by Type (2021-2032)
  6. 10.4 China Nitric Oxide Therapy System Revenue by Application (2021-2032)
  7. 10.4.1 China Nitric Oxide Therapy System Revenue by Application (2021-2026)
  8. 10.4.2 China Nitric Oxide Therapy System Revenue by Application (2027-2032)
  9. 10.5 China Nitric Oxide Therapy System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nitric Oxide Therapy System Revenue (2021-2032)
  2. 11.2 Asia Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nitric Oxide Therapy System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nitric Oxide Therapy System Revenue by Type (2027-2032)
  5. 11.3 Asia Nitric Oxide Therapy System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nitric Oxide Therapy System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nitric Oxide Therapy System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nitric Oxide Therapy System Revenue by Application (2027-2032)
  9. 11.5 Asia Nitric Oxide Therapy System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nitric Oxide Therapy System Revenue by Country
  11. 11.6.1 Asia Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nitric Oxide Therapy System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nitric Oxide Therapy System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nitric Oxide Therapy System Revenue (2021-2032)
  2. 12.2 SAMEA Nitric Oxide Therapy System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nitric Oxide Therapy System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nitric Oxide Therapy System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nitric Oxide Therapy System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nitric Oxide Therapy System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nitric Oxide Therapy System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nitric Oxide Therapy System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nitric Oxide Therapy System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nitric Oxide Therapy System Revenue by Country
  11. 12.6.1 SAMEA Nitric Oxide Therapy System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nitric Oxide Therapy System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nitric Oxide Therapy System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst